Variant report
Variant | nsv601144 |
---|---|
Chromosome Location | chr6:23915870-23924231 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs474833 | chr6:23915870-23915871 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs372968352 | chr6:23915898-23915899 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs474923 | chr6:23915899-23915900 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs534856286 | chr6:23915914-23915915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370486436 | chr6:23915915-23915916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186772465 | chr6:23915937-23915938 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532043353 | chr6:23915954-23915955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543753359 | chr6:23915990-23915991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs191144641 | chr6:23916001-23916002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553161809 | chr6:23916004-23916005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574546118 | chr6:23916091-23916092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547945858 | chr6:23916138-23916139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200469591 | chr6:23916155-23916156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566195571 | chr6:23916159-23916160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140410177 | chr6:23916182-23916183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563671646 | chr6:23916188-23916189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575578982 | chr6:23916196-23916197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77917837 | chr6:23916216-23916217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371981455 | chr6:23916231-23916232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs56326519 | chr6:23916243-23916244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373713055 | chr6:23916251-23916252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537392088 | chr6:23916263-23916264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113175617 | chr6:23916352-23916353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370368094 | chr6:23916405-23916406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144151388 | chr6:23916421-23916422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567149373 | chr6:23916446-23916447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145472432 | chr6:23916450-23916451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552714267 | chr6:23916499-23916500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184058900 | chr6:23916518-23916519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs377675392 | chr6:23916524-23916525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544739758 | chr6:23916525-23916526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545904982 | chr6:23916561-23916562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186829375 | chr6:23916578-23916579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs370912090 | chr6:23916590-23916591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565145178 | chr6:23916596-23916597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575130149 | chr6:23916597-23916598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374525260 | chr6:23916606-23916607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs78159679 | chr6:23916638-23916639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529578915 | chr6:23916653-23916654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74486495 | chr6:23916659-23916660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs58258947 | chr6:23916667-23916668 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs533474408 | chr6:23916672-23916673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149208454 | chr6:23916674-23916675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143885020 | chr6:23916683-23916684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs503618 | chr6:23916703-23916704 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs143385196 | chr6:23916773-23916774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs529890420 | chr6:23916794-23916795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569112740 | chr6:23916799-23916800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10715713 | chr6:23916846-23916847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533838873 | chr6:23916849-23916850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:23911600-23916000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr6:23915600-23916400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr6:23915800-23916400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr6:23915800-23917000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr6:23916000-23916400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr6:23917000-23921800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr6:23921800-23923600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr6:23922000-23924000 | Enhancers | Primary hematopoietic stem cells | blood |
9 | chr6:23922600-23923200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |